secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2025-07-21T23:59:59+00:00
Accession:  0001104659-25-069258
Event type: debt
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acura receives two $100K loans from AD Pharma; warns of possible operations halt if no further financing by Aug 2025
--------------------------------------------------------------------------------

- Principal on secured note rises to $8,394,279 with ~$740K accrued interest; interest rate 5.25%.
- Loans of $100K each on July 3 and July 18, 2025 from Abuse Deterrent Pharma, LLC (AD Pharma).
- Without additional financing by early August 2025, company may furlough employees or seek bankruptcy protection.
- AD Pharma owns ~65% of outstanding common stock (excludes warrant for 10M shares).
- Funds used for day-to-day operations; no assurance of further financing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465925069258/0001104659-25-069258-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465925069258/tm2521314d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-069258

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer